TG Therapeutics

TGTX

NASDAQHealth Care

Income Statement

Total Revenue$329M

Gross Profit$290.52M

Operating Income$41.93M

EBITDA$49.82M

EBIT$49.75M

Pre-tax Income$122.29M

Net Income$23.38M

Cash Equivalent$134.82M

Total Debt$181.66M

Book Value$188.05M

Book Value Per Share1.21

Return on Equity (ROE)+10.52%

Return on Assets (ROA)+4.05%

Return on Invested Capital (ROI)+5.01%

Net Profit Margin+7.11%

Current Ratio6.25

Quick Ratio5.03

Long-Term Debt / Equity1.10